Intraoperative surgical complications of open surgery for congenital diaphragmatic hernia: a multicenter, observational study in Japan.

Autor: Terui K; Division of Pediatric Surgery, Department of Surgery, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 329-0498, Japan. kta@cc.rim.or.jp.; Department of Pediatric Surgery, Chiba University Graduate School of Medicine, Chiba, Japan. kta@cc.rim.or.jp., Nagata K; Department of Pediatric Surgery, Reproductive and Developmental Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Yamoto M; Department of Pediatric Surgery, Shizuoka Children's Hospital, Shizuoka, Japan., Sato Y; Division of Neonatology, Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan., Okuyama H; Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Maruyama H; Division of Neonatology, National Center for Child Health and Development, Tokyo, Japan., Yokoi A; Department of Pediatric Surgery, Kobe Children's Hospital, Kobe, Japan., Kim K; Department of Pediatric Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Masumoto K; Department of Pediatric Surgery, Tsukuba University, Tsukuba, Japan., Okazaki T; Department of Pediatric Surgery, Juntendo University Urayasu Hospital, Tokyo, Japan., Inamura N; Department of Pediatrics, Kindai University, Osaka, Japan., Toyoshima K; Department of Neonatology, Kanagawa Children's Medical Center, Yokohama, Japan., Koike Y; Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Mie, Japan., Yazaki Y; Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan., Sato Y; Department of Preventive Medicine and Public Health, Keio University, Tokyo, Japan., Usui N; Department of Pediatric Surgery, Osaka Women's and Children's Hospital, Osaka, Japan.

Publikováno v: Pediatric surgery international [Pediatr Surg Int] 2024 Aug 22; Vol. 40 (1), pp. 240. Date of Electronic Publication: 2024 Aug 22.

COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production.

Autor: Nakamoto T; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan. tnakamoto@hosp.ncgm.go.jp., Iwamoto N; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan., Oshiro Y; Clinical Laboratory, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan., Inamura N; Clinical Laboratory, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan., Nemoto T; Clinical Laboratory, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan., Ide S; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan., Nakamura K; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan.; Center for the Study fo Global IInfection, Kushu University Hospital, Fukuoka, Japan., Nomoto H; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan., Akiyama Y; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan., Suzuki T; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan., Miyazato Y; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan., Suzuki M; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan., Suzuki K; AMR Clinical Reference Center, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan., Kimura M; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Tokyo, 162-8655, Japan., Saito S; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan., Kutsuna S; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan.; Department of Infection Control, Graduate School of Medicine / Faculty of Medicine, Osaka University, Suita City, Osaka, 565-0871, Japan., Ohmagari N; Disease Control and Prevention Center/Travel Clinic, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-Ku, Tokyo, 162-8655, Japan.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2024 Oct 24; Vol. 24 (1), pp. 1197. Date of Electronic Publication: 2024 Oct 24.

Protection of Omicron Bivalent Vaccine, Previous Infection, and Their Induced Neutralizing Antibodies Against Symptomatic Infection With Omicron XBB.1.16 and EG.5.1.

Autor: Yamamoto S; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Matsuda K; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan., Maeda K; Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.; Department of Refractory Viral Infection, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan., Mizoue T; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Horii K; Infection Control Office, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Okudera K; Infection Control Office, Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan., Tan T; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Oshiro Y; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Inamura N; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Nemoto T; Department of Laboratory Testing, Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., S Takeuchi J; Department of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Konishi M; Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Sugiyama H; Center Hospital of the National Center for the Global Health and Medicine, Tokyo, Japan., Aoyanagi N; Kohnodai Hospital of the National Center for the Global Health and Medicine, Chiba, Japan., Sugiura W; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan., Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Sep 06; Vol. 11 (9), pp. ofae519. Date of Electronic Publication: 2024 Sep 06 (Print Publication: 2024).

Promyelinating drugs ameliorate oligodendrocyte pathologies in a mouse model of Krabbe disease.

Autor: Inamura N; Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya-cho, Kasugai, Aichi 480-0392, Japan., Kawai T; Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya-cho, Kasugai, Aichi 480-0392, Japan., Watanabe T; Department of Pathophysiology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan., Aoki H; Department of Pathobiology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan., Aoyama M; Department of Pathobiology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan., Nakayama A; Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya-cho, Kasugai, Aichi 480-0392, Japan; Department of Neurobiochemistry, Nagoya University School of Medicine, Nagoya, Aichi 466-8560, Japan., Matsuda J; Department of Pathophysiology and Metabolism, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan., Enokido Y; Department of Cellular Pathology, Institute for Developmental Research, Aichi Developmental Disability Center, 713-8 Kamiya-cho, Kasugai, Aichi 480-0392, Japan. Electronic address: enokido@inst-hsc.jp.

Publikováno v: Molecular genetics and metabolism [Mol Genet Metab] 2024 Jul; Vol. 142 (3), pp. 108497. Date of Electronic Publication: 2024 May 15.

Assessment of pulmonary artery size at birth as a prognostic factor in congenital diaphragmatic hernia: results of a multicenter study in Japan.

Autor: Okazaki T; Department of Pediatric Surgery, Juntendo University Urayasu Hospital, Chiba, Japan. okazakit@juntendo.ac.jp., Terui K; Department of Pediatric Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan., Nagata K; Department of Pediatric Surgery, Kyushu University, Fukuoka, Japan., Hayakawa M; Center for Maternal-Neonatal Care, Nagoya University Hospital, Nagoya, Japan., Okuyama H; Department of Pediatric Surgery, Osaka University Graduate School of Medicine, Osaka, Japan., Amari S; Division of Neonatology, National Center for Child Health and Development, Tokyo, Japan., Masumoto K; Department of Pediatric Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan., Yamoto M; Department of Pediatric Surgery, Shizuoka Children's Hospital, Shizuoka, Japan., Inamura N; Department of Pediatrics, Kindai University, Faculty of Medicine, Osaka-Sayama, Japan., Toyoshima K; Departments of Neonatology, Kanagawa Children's Medical Center, Yokohama, Japan., Furukawa T; Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan., Okawada M; Department of Pediatric General and Urogenital Surgery, Juntendo University School of Medicine, Tokyo, Japan., Yokoi A; Department of Pediatric Surgery, Hyogo Children's Hospital, Hyogo, Japan., Koike Y; Department of Pediatric Surgery, Mie University, Mie, Japan., Nojiri S; Medical Technology Innovation Center, Clinical Research and Trial Center, Juntendo University, Tokyo, Japan., Nishizaki Y; Division of Medial education, Juntendo University School of Medicine, Tokyo, Japan., Yanagisawa N; Medical Technology Innovation Center, Clinical Research and Trial Center, Juntendo University, Tokyo, Japan., Usui N; Department of Pediatric Surgery, Osaka Women's and Children's Hospital, Izumi, Japan.

Publikováno v: Journal of perinatology : official journal of the California Perinatal Association [J Perinatol] 2023 Oct; Vol. 43 (10), pp. 1295-1300. Date of Electronic Publication: 2023 Aug 15.